Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 07; 368(10):924-35.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Anti-Allergic Agents
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal, Humanized
Child
Chronic Disease
Double-Blind Method
Female
Humans
Intention to Treat Analysis
Male
Middle Aged
Omalizumab
Pruritus
Severity of Illness Index
Urticaria
Young Adult
authors with profiles
Allen P. Kaplan